Notable Downgrades: SUNE, BCRX, ORCL, RICE, SNDK

SunEdison, Inc. (SUNE) was reiterated a ‘Neutral’ by UBS analysts on Wednesday. The broker also cut its price target on the stock to $6 from $9. SUNE was down $0.88 at $4.89 in mid-day trade, moving within a 52-week range of $4.75 to $33.45. The name, valued at $1.54 billion, opened at $5.70. BioCryst Pharmaceuticals, […] View the full post at: Notable Downgrades: SUNE, BCRX, ORCL, RICE, SNDK Related posts: John Rice: No Green Shoots Here Top Pre-Market Stock Upgrades/Downgrades April 8, 2010 Oracle (ORCL) Looks Downright Visionary